Generex Biotechnology Corp – Company Profile & SWOT Analysis

Generex Biotechnology Corp – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company”™s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using proprietary RapidMist device. Generex through its subsidiary, Antigen Express, has expanded its focus to include immunomedicines incorporating proprietary vaccine formulations for the treatment of infectious, malignant, allergic, and autoimmune diseases. Generex is headquartered in Miramar, Florida, the US.

Scope

Detailed information on Generex Biotechnology Corp required for business and competitor intelligence needs

A study of the major internal and external factors affecting Generex Biotechnology Corp in the form of a SWOT analysis

An in-depth view of the business model of Generex Biotechnology Corp including a breakdown and examination of key business segments

News about Generex Biotechnology Corp, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Generex Biotechnology Corp and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Generex Biotechnology Corp as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Generex Biotechnology Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

StageZero Life Sciences Ltd

Sernova Corp

Novo Nordisk AS

Novavax Inc

Merck & Co Inc

MedImmune, Inc.

GlaxoSmithKline Plc

Eli Lilly and Co

Aptose Biosciences Inc

Apotex Inc

Ambrilia Biopharma Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Generex Biotechnology Corp - Key Facts

Generex Biotechnology Corp - Key Employees

Generex Biotechnology Corp - Key Employee Biographies

Generex Biotechnology Corp - Major Products and Services

Generex Biotechnology Corp - History

Generex Biotechnology Corp - Company Statement

Generex Biotechnology Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Generex Biotechnology Corp - Business Description

Generex Biotechnology Corp - SWOT Analysis

SWOT Analysis - Overview

Generex Biotechnology Corp - Strengths

Generex Biotechnology Corp - Weaknesses

Generex Biotechnology Corp - Opportunities

Generex Biotechnology Corp - Threats

Generex Biotechnology Corp - Key Competitors

Section 3 Company”™s Lifesciences Financial Deals and Alliances

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Generex Biotechnology Corp, Recent Deals Summary

Section 4 Company”™s Recent Developments

Dec 11, 2019: Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors

Sep 27, 2019: Generex Biotechnology announces plans to establish the NuGenerex Diabetes Research Center in collaboration with Arizona Endocrinology Group & Paradise Valley Medical Family Medicine

Sep 12, 2019: Generex Biotechnology announces webcast and invites all shareholders to see and listen to the corporate presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference

Sep 10, 2019: Generex Biotechnology Signs Letters of Intent to establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine

Aug 01, 2019: Generex Biotechnology welcomes MediSource Partners to the NuGenerex Family of Companies

Jul 31, 2019: Generex Biotechnology introduces Pantheon Medical, the newest member of the NuGenerex family of Companies

Jul 12, 2019: Generex Biotechnology acquires Pantheon Medical

Jul 10, 2019: Generex Biotechnology provides fiscal year overview

Jun 03, 2019: Generex Biotechnology announces date for rescheduled May 15th Investor Conference Call

Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors

Section 5 Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Generex Biotechnology Corp, Key Facts

Generex Biotechnology Corp, Key Employees

Generex Biotechnology Corp, Key Employee Biographies

Generex Biotechnology Corp, Major Products and Services

Generex Biotechnology Corp, History

Generex Biotechnology Corp, Subsidiaries

Generex Biotechnology Corp, Key Competitors

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Generex Biotechnology Corp, Recent Deals Summary

List of Figures

List of Figures

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Generex Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports